Hydroxyurea and Xeroderma - a phase IV clinical study of FDA data
Summary:
We study 17,678 people who take Hydroxyurea (hydroxyurea) or have Xeroderma. No report of Xeroderma is found in people who take Hydroxyurea.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
What is Hydroxyurea?
Hydroxyurea has active ingredients of hydroxyurea. It is often used in polycythemia vera. eHealthMe is studying from 17,240 Hydroxyurea users. Check the latest studies of Hydroxyurea.
What is Xeroderma?
Xeroderma (dry skin include itching and red, cracked or flaky skin) is found to be associated with 45 drugs and 291 conditions by eHealthMe. Check the latest studies of Xeroderma.
No report is found.
Do you take Hydroxyurea and have Xeroderma?
- Check whether Xeroderma is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Hydroxyurea:
- Hydroxyurea (17,240 reports)
Xeroderma treatments and more:
- Xeroderma (438 reports)
How severe was Xeroderma and when was it recovered:
Expand to all the drugs that have ingredients of hydroxyurea:
Browse all side effects of Hydroxyurea:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Xeroderma:
Browse all the conditions that are associated with Xeroderma:
How the study uses the data?
The study uses data from the FDA. It is based on hydroxyurea (the active ingredients of Hydroxyurea) and Hydroxyurea (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Prograf and Renal Tubular Necrosis for Women aged 30-39 - a second ago
- Abilify and Pulmonary Embolism for Women aged 50-59 - 2 seconds ago
- Abilify and Pulmonary Embolus for Women aged 50-59 - 3 seconds ago
- Leukopenia and drugs of ingredients of oxycodone hydrochloride - 7 seconds ago
- Could Ocrevus cause Dental Caries? - 9 seconds ago
- Diphen and Injection Site Pruritus for Men aged 60+ - 11 seconds ago
- Agitation and Drowsiness - 14 seconds ago
- Hypertonic Bladder and Nausea Aggravated - 14 seconds ago
- Colecalciferol and Headache for Women aged 20-29 - 17 seconds ago
- Colecalciferol and Frequent Headaches for Women aged 20-29 - 17 seconds ago